Effect of Highly Active Antiretroviral Therapy on Survival in Patients With AIDS-Associated Pulmonary Kaposi’s Sarcoma Treated With Chemotherapy
- 15 September 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (18), 3848-3851
- https://doi.org/10.1200/jco.2001.19.18.3848
Abstract
PURPOSE: Kaposi’s sarcoma (KS) is the most common AIDS-related malignancy. Pulmonary involvement by KS (PKS) has carried a poor prognosis with median reported survival ranging from 3 to 10 months. ...Keywords
This publication has 19 references indexed in Scilit:
- The Epidemiologic, Pathologic, and Clinical Features of AIDS-Associated Pulmonary Kaposi's SarcomaChest, 2000
- DECLINE IN HIV-ASSOCIATED KAPOSI'S SARCOMA (KS) AND NON-HODGKIN'S LYMPHOMA (NHL) FOLLOWING THE INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART).JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.Journal of Clinical Oncology, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- THE EPIDEMIOLOGY OF AIDS-RELATED NEOPLASMSHematology/Oncology Clinics of North America, 1996
- Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma.Thorax, 1994
- The Effects on Survival of Early Treatment of Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Pulmonary Kaposi's Sarcoma: Clinical Findings and Results of TherapyThe American Journal of Medicine, 1989
- Pulmonary Manifestations of Kaposi’s SarcomaChest, 1987
- Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndromeThe American Journal of Medicine, 1986